TIS 0.00% 0.0¢ tissue therapies limited

relax regarding ce and website, page-17

  1. 224 Posts.
    lightbulb Created with Sketch. 4
    Matt : from the announcement dated 27 March 12, second page :

    "Large scale manufacturing of commercial batches of VitroGro® was required for validation and regulatory approval. The difference between supply and demand only applies to the initial batches of VitroGro® because progressive expiry date extension of each subsequent batch and increasing sales will align production and demand."
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.